Education
About Us
Working with TipRanks
Follow Us
Allurion Technologies (ALUR)
NYSE:ALUR
ALUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.37 - $98.75
Previous CloseN/A
Volume63.90K
Average Volume (3M)2.96M
Market Cap
$17.02M
Enterprise Value$50.16M
Total Cash (Recent Filing)$38.04M
Total Debt (Recent Filing)$41.86M
Price to Earnings (P/E)―
Beta3.24
Next Earnings
Mar 20, 2025EPS Estimate
-5.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-11.89
Shares Outstanding4,793,191
10 Day Avg. Volume485,033
30 Day Avg. Volume2,956,341
Standard Deviation0.22
R-Squared0.30
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.36
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap2.95
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.21
Enterprise Value/Ebitda-2.33
Forecast
1Y Price Target
$16.00Price Target Upside390.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Bulls Say, Bears Say
Bulls Say
Clinical Trial SuccessThe Audacity study succeeded in the responder rate co-primary endpoint, with 58% of Allurion balloon patients losing more than 5% of their total body weight at 48 weeks.
International BusinessThe Allurion Balloon has been cleared to resume sales in France, removing a major overhang on the international business.
US Market ExpansionALUR remains on track for a top-line readout of its Audacity study by year-end, which could greatly increase the Allurion Balloon's prospects for US approval and should be a major positive stock catalyst.
Bears Say
Market SetbackThe setback in France, with the suspension of sales by the regulatory body ANSM, is considered manageable and is not expected to derail ALUR's overall growth.
Price Target DecreaseThe price target for Allurion Technologies, Inc. has been significantly lowered.
---
Ownership Overview
21.17% Insiders
26.31% Mutual Funds
― Other Institutional Investors
28.03% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ALUR FAQ
What was Allurion Technologies’s price range in the past 12 months?
Allurion Technologies lowest stock price was $2.37 and its highest was $98.75 in the past 12 months.
What is Allurion Technologies’s market cap?
Allurion Technologies’s market cap is $17.02M.
When is Allurion Technologies’s upcoming earnings report date?
Allurion Technologies’s upcoming earnings report date is Mar 20, 2025 which is in 21 days.
How were Allurion Technologies’s earnings last quarter?
Allurion Technologies released its earnings results on Nov 13, 2024. The company reported -$3.5 earnings per share for the quarter, beating the consensus estimate of -$4.562 by $1.062.
Is Allurion Technologies overvalued?
According to Wall Street analysts Allurion Technologies’s price is currently Undervalued.
Does Allurion Technologies pay dividends?
Allurion Technologies does not currently pay dividends.
What is Allurion Technologies’s EPS estimate?
Allurion Technologies’s EPS estimate is -5.34.
How many shares outstanding does Allurion Technologies have?
Allurion Technologies has 4,793,191 shares outstanding.
What happened to Allurion Technologies’s price movement after its last earnings report?
Allurion Technologies reported an EPS of -$3.5 in its last earnings report, beating expectations of -$4.562. Following the earnings report the stock price went down -26.351%.
Which hedge fund is a major shareholder of Allurion Technologies?
Currently, no hedge funds are holding shares in ALUR
---
Allurion Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$16.00 (390.80% Upside)
$16.00 (390.80% Upside)
Blogger Sentiment
Bullish
ALUR Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 51.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▲ 10.5%
Last 30 Days ▲ 10.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-95.42%
12-Months-Change
Fundamentals
Return on Equity
38.80%
Trailing 12-Months
Asset Growth
-57.99%
Trailing 12-Months
Company Description
Allurion Technologies
Compute Health Acquisition Corp is a blank check company.
---
ALUR Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a challenging quarter with significant revenue decline and operational difficulties, particularly in France. However, there are promising aspects such as substantial growth in AI product revenue, a new commercial strategy, and positive data from recent studies. The company is focused on restructuring and strategic initiatives to return to growth.Read More>---
ALUR Stock 12 Month Forecast
Average Price Target
$16.00
▲(390.80% Upside)
Technical Analysis
NovoCure
―
Tactile Systems Technology
―
Irhythm Technologies
―
Inspire Medical Systems
―
Butterfly Network
―
Best Analysts Covering ALUR
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-62.45%
reiterated a buy rating 15 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -62.45% per trade.
---